Last edition
News about "India Business Excellence Fund"
Symbiotec Pharmalab to Open IPO for Subscription on August 24, 2026
Symbiotec Pharmalab will open its IPO for subscription from August 24–27, 2026, with a price band of INR 938–INR 988 per share and an OFS component of up to INR 1,607 crore.
India Business Excellence Fund | 20/08/2026 | By News Bureau
Symbiotec Pharmalab Files Draft Papers to Raise INR 2,180 Crore via IPO
Symbiotec Pharmalab Ltd has filed draft red herring prospectus papers with the Securities and Exchange Board of India to raise INR 2,180 crore through an initial public offering.
India Business Excellence Fund | 20/12/2025 | By Darshana | 274
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy